Off-Label Drug Campaigns Unlikely To Disappear


As written by the Associated Press, the huge fine levied last week against Pfizer is unlikely to stop pharmaceutical companies from the profitable practice of off-label marketing of prescription drugs. Drugs are approved by the government for particular uses, but obviously drug manufacturers can make more money if they can promote their drugs as the solution for as many different diseases as possible. So the temptation is for drug companies to try to convince doctors to prescribe medications for purposes other than those approved by the FDA. This is a potentially dangerous practice, simply because the regulating agency has not tested the drugs for these off-label purposes. Here are excerpts from the article...

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robert Kraft, Kraft & Associates | Attorney Advertising

Written by:


Kraft & Associates on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.